In sign of MAHA’s influence, EPA is holding up forever chemical approvals
The Breakdown
The Environmental Protection Agency (EPA), under the leadership of Administrator Lee Zeldin, is delaying the approval of dozens of applications for new uses of PFAS substances, or “forever chemicals.” This hesitancy, catalyzed by concerns over backlash from Make America Healthy Again (MAHA) activists, marks a significant shift in the regulatory environment for specialty chemicals and polymers. The growing scrutiny of PFAS underscores a broader uncertainty for stakeholders across the value chain as regulatory decision-making is increasingly shaped by public sentiment and advocacy pressures.
Analyst View
The ongoing delays signal a complex convergence of regulatory and societal forces impacting market access for innovative and legacy chemistries. As federal oversight intensifies and advocacy groups gain traction, the path to commercialization for specialty polymers involving PFAS becomes less predictable. These shifts impose significant constraints on strategic growth planning, capital allocation, and the overall willingness to invest in PFAS-related technologies—even for applications with established demand.
This uncertainty pressures suppliers, formulators, and downstream users to re-evaluate their portfolios, with ripple effects extending through the value chain. Substitutes and alternative chemistries are likely to attract renewed investment, while collaboration with regulatory bodies and channel partners becomes an essential strategic lever. At the same time, the ability for organizations to forecast demand and align with the evolving regulatory climate will distinguish market leaders from laggards. In this environment, forward-looking risk management and agile scenario planning are not optional—they are strategic imperatives.
Navigating the Signals
Business leaders must recognize that market acceptance for PFAS and related chemistries can shift rapidly—influenced not solely by regulators, but by broader stakeholder activism. This dynamic can dramatically accelerate or decelerate adoption cycles. Organizations should consider: What is the real risk of abrupt regulatory change? How coordinated are our upstream and downstream partners in responding to policy shifts? Which emerging voices or advocacy groups have the capacity to affect our licensing and approval roadmap?
Leaders should prepare for heightened scenario volatility, and be proactive in their risk sensing mechanisms. Developing robust engagement strategies with opinion influencers and regulators alike will be critical, as will ongoing investment in technology scouting and secondary supply pathways. The ability to rapidly adapt product strategy in response to legislative delays or advocacy-driven market pushback will define sustainable competitive advantage.
What’s Next?
Breakthrough Marketing Technology enables science-driven enterprises to anticipate and respond to regulatory and advocacy-driven disruptions by providing:
- Real-time insights into stakeholder sentiment and regulatory signals, so your teams are never blindsided by policy shifts.
- Scenario modeling tools that stress-test portfolio strategies under multiple market access timelines.
- Market mapping to identify emerging influencers and channel vulnerabilities before they impact your growth trajectory.
- Bespoke risk communication strategies to strengthen alignment with value chain partners and manage market perception.
Strategic intelligence from Breakthrough Marketing Technology empowers leadership to move decisively, mitigate uncertainty, and accelerate value capture—despite undeniable complexity.
Source
Understand Your Risk. Seize Your Opportunity.
Take the Breakthrough Market Uncertainty Assessment Guide to pinpoint what’s holding your growth back, and what can accelerate it.
